Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_assertion type Assertion NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_head.
- NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_assertion description "[Sensitivity of the prostate cancer antigen 3 test could be improved by the detection of the fusion gene transcripts transmembrane protease serine 2-E26 transformation specific-related gene and serine peptidase inhibitor Kazal type 1 who may in addition allow the identification of prostate cancer patients at higher risk of life-threatening disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_provenance.
- NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_assertion evidence source_evidence_literature NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_provenance.
- NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_assertion SIO_000772 19325493 NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_provenance.
- NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_assertion wasDerivedFrom befree-2016 NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_provenance.
- NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_assertion wasGeneratedBy ECO_0000203 NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_provenance.